169 related articles for article (PubMed ID: 2452418)
1. The efficacy, electrophysiologic and electrocardiographic effects of intravenous pirmenol, a new class I antiarrhythmic agent, in patients with ventricular tachycardia: comparison with procainamide.
Gold RL; Frumin H; Haffajee CI; Kerin NZ; Jarandilla R
Pacing Clin Electrophysiol; 1988 Mar; 11(3):308-14. PubMed ID: 2452418
[TBL] [Abstract][Full Text] [Related]
2. Electrocardiographic and electrophysiologic effects of pirmenol in ventricular tachycardia.
Estes NA; Gold R; Cameron J; Haffajee C; Marshall M; Mack K; Salem DN
Am J Cardiol; 1987 Jun; 59(16):20H-26H. PubMed ID: 3591711
[TBL] [Abstract][Full Text] [Related]
3. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy of pirmenol and procainamide in a drug-resistant population with ventricular tachycardia.
Miura DS; Schwartz J; Laux B; Wynn J; Keefe D; Somberg JC
J Clin Pharmacol; 1987 Jul; 27(7):481-6. PubMed ID: 3654999
[TBL] [Abstract][Full Text] [Related]
5. Electrophysiologic evaluation of pirmenol for sustained ventricular tachycardia secondary to coronary artery disease.
Easley AR; Mann DE; Reiter MJ; Sakun V; Sullivan SM; Magro SA; Luck JC; Wyndham CR
Am J Cardiol; 1986 Jul; 58(1):86-9. PubMed ID: 3728337
[TBL] [Abstract][Full Text] [Related]
6. Acute electrophysiologic effects of pirmenol in normal subjects and in patients with Wolff-Parkinson-White syndrome.
Brown JE; Yee R; Klein GJ
Am J Cardiol; 1986 Apr; 57(10):775-81. PubMed ID: 3962864
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiology and antiarrhythmic efficacy of intravenous pirmenol in patients with sustained ventricular tachyarrhythmias.
Liem LB; Clay DA; Franz MR; Swerdlow CD
Am Heart J; 1987 Jun; 113(6):1390-6. PubMed ID: 3591608
[TBL] [Abstract][Full Text] [Related]
8. Electropharmacologic effect of a standard dose of intravenous procainamide in patients with sustained ventricular tachycardia.
Rials SJ; Britchkow D; Marinchak RA; Kowey PR
Clin Cardiol; 2000 Mar; 23(3):171-4. PubMed ID: 10761804
[TBL] [Abstract][Full Text] [Related]
9. Effects of pirmenol on electrical induction of sustained ventricular tachycardia in a seven-day-old canine myocardial infarction.
Nitta J; Nogami A; Aonuma K; Akimoto H; Chung YH; Takahashi A; Iesaka Y; Marumo F; Hiraoka M
J Cardiovasc Pharmacol; 1991 Jan; 17(1):54-60. PubMed ID: 1708056
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiologic properties and antiarrhythmic mechanisms of intravenous N-acetylprocainamide in patients with ventricular dysrhythmias.
Sung RJ; Juma Z; Saksena S
Am Heart J; 1983 May; 105(5):811-9. PubMed ID: 6189384
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacology and pharmacokinetics of pirmenol.
Reiter MJ
Angiology; 1988 Mar; 39(3 Pt 2):293-8. PubMed ID: 3281518
[TBL] [Abstract][Full Text] [Related]
12. Electrophysiologic and clinical factors influencing response to class IA antiarrhythmic agents in patients with inducible sustained monomorphic ventricular tachycardia.
Gold RL; Haffajee CI; Alpert JS
Am Heart J; 1986 Jul; 112(1):9-13. PubMed ID: 3728294
[TBL] [Abstract][Full Text] [Related]
13. Antiarrhythmic effects of cibenzoline.
Miura DS; Keren G; Torres V; Butler B; Aogaichi K; Somberg JC
Am Heart J; 1985 Apr; 109(4):827-33. PubMed ID: 3984837
[TBL] [Abstract][Full Text] [Related]
14. Effects of procainamide and lidocaine on electrically inducible ventricular tachycardia studied with programmed ventricular stimulation in post myocardial infarction.
Iesaka Y; Aonuma K; Nitta J; Tokunaga T; Fujiwara H; Hiraoka M
Jpn Circ J; 1988 Mar; 52(3):262-71. PubMed ID: 3373718
[TBL] [Abstract][Full Text] [Related]
15. The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans.
Sager PT; Follmer C; Uppal P; Pruitt C; Godfrey R
Circulation; 1994 Oct; 90(4):1811-9. PubMed ID: 7923666
[TBL] [Abstract][Full Text] [Related]
16. Limited role of intravenous propafenone hydrochloride in the treatment of sustained ventricular tachycardia: electrophysiologic effects and results of programmed ventricular stimulation.
Doherty JU; Waxman HL; Kienzle MG; Cassidy DM; Marchlinski FE; Buxton AE; Josephson ME
J Am Coll Cardiol; 1984 Aug; 4(2):378-81. PubMed ID: 6736479
[TBL] [Abstract][Full Text] [Related]
17. Efficacy, safety, and tolerance of d-sotalol in patients with refractory supraventricular tachyarrhythmias.
Sahar DI; Reiffel JA; Bigger JT; Squatrito A; Kidwell GA
Am Heart J; 1989 Mar; 117(3):562-8. PubMed ID: 2919535
[TBL] [Abstract][Full Text] [Related]
18. Anti-arrhythmic efficacy of nifekalant hydrochloride, a pure class III anti-arrhythmic agent, in patients with healed myocardial infarction and inducible sustained ventricular tachycardia.
Igawa M; Aonuma K; Okamoto Y; Hiroe M; Hiraoka M; Isobe M
J Cardiovasc Pharmacol; 2002 Nov; 40(5):735-42. PubMed ID: 12409982
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of nadolol alone or in combination with a type IA antiarrhythmic drug in sustained ventricular tachycardia: a prospective study.
Munsif AN; Saksena S
Pacing Clin Electrophysiol; 1989 Nov; 12(11):1816-26. PubMed ID: 2478982
[TBL] [Abstract][Full Text] [Related]
20. Prolongation of ventricular refractoriness by class Ia antiarrhythmic drugs in the prevention of ventricular tachycardia induction.
Kus T; Costi P; Dubuc M; Shenasa M
Am Heart J; 1990 Oct; 120(4):855-63. PubMed ID: 2220538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
